Mitochondria: A target for cancer therapy

British Journal of Pharmacology

Volumn 147, Issue 3, 2006, Pages 239-248

  Armstrong, Jeffrey S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Bax; Bcl 2; BH3 domain; Cancer; Cyclosporine A; Mitochondria; Mitochondrial membrane permeabilization; Mitochondrial membrane potential; Mitochondrial permeability transition; Reactive oxygen species

Indexed keywords

1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE; 4 QUINOLONE DERIVATIVE; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADENOVIRUS VECTOR; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CALCIUM; CIPROFLOXACIN; CISPLATIN; CYCLOSPORIN A; CYTOCHROME C; DITERCALINIUM; DOXORUBICIN; ETHIDIUM BROMIDE; IMMUNOSUPPRESSIVE AGENT; LONIDAMINE; MASTOPARAN; MATRIX METALLOPROTEINASE; NUCLEOSIDE ANALOG; OBLIMERSEN; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; REACTIVE OXYGEN METABOLITE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; THIOL DERIVATIVE; VPR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER THERAPY; CLINICAL TRIAL; DRUG TARGETING; ENZYME RELEASE; GENE THERAPY; HUMAN; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL MEMBRANE PERMEABILITY; CYCLOSPORINE; CYTOCHROMES C; DNA, MITOCHONDRIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL MEMBRANES; PEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; WASP VENOMS;

EID: 32244436232     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706556     Document Type: Review

References (115)

1. ACKERMANN, E.J., TAYLOR, J.K., NARAYANA, R. & BENNETT, C.F. (1999). The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem., 274, 11245-11252.
2. ADACHI, M., HIGUCHI, H., MIURA, S., AZUMA, T., INOKUCHI, S., SAITO, H., KATO, S. & ISHII, H. (2004). Bax interacts with the voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G695-G705.
3. ANDERSON, K.S. (2001). The molecular basis of inhibition and toxicity of modified cytosine analogues targeting HIV-1 reverse transcriptase. Antivir. Chem. Chemother., 12 (Suppl 1), 13-17.
4. AQEILAN, R., YARKONI, S. & LORBERBOUM-GALSKI, H. (1999). Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy. FEBS Lett., 457, 271-276.
5. ARDAIL, D., PRIVAT, J.P., EGRET-CHARLIER, M., LEVRAT, C., LERME, F. & LOUISOT, P. (1990). Mitochondrial contact sites. Lipid composition and dynamics. J. Biol. Chem., 265, 18797-18802.
6. ARMSTRONG, J.S. & JONES, D.P. (2002). Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J., 16, 1263-1265.
7. ARMSTRONG, J.S., STEINAUER, K.K., HORNUNG, B., IRISH, J.M., LECANE, P., BIRRELL, G.W., PEEHL, D.M. & KNOX, S.J. (2002). Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ., 9, 252-263.
8. ARMSTRONG, J.S., WHITEMAN, M., YANG, H., JONES, D.P. & STERNBERG, JR P. (2004). Cysteine starvation activates the redox-dependent mitochondrial permeability transition in retinal pigment epithelial cells. Invest. Ophlhalmol. Vis. Sci., 45, 4183-4189.
9. BAINES, C.P., KAISER, R.A., PURCELL, N.H., BLAIR, N.S., OSINSKA, H., HAMBLETON, M.A., BRUNSKILL, E.W., SAYEN, M.R., GOTTLIEB, R.A., DORN, G.W., ROBBINS, J. & MOLKENTIN, J.D. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 434, 658-662.
10. BRECKENRIDGE, D.G. & XUE, D. (2004). Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr. Opin. Cell Biol., 16, 647-652.
11. BREDESEN, D.E. (2000). Apoptosis: overview and signal transduction pathways. J. Neurotrauma, 17, 801-810.
12. BRENNER, C., CADIOU, H., VIEIRA, H.L., ZAMZAMI, N., MARZO, I., XIE, Z., LEBER, B., ANDREWS, D., DUCLOHIER, H., REED, J.C. & KROEMER, G. (2000). Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene, 19, 329-336.
13. BRINI, M., MARSAULT, R., BASTIANUTTO, C., ALVAREZ, J., POZZAN, T. & RIZZUTO, R. (1995). Transfected aequorin in the measurement of cytosolic Ca2+ concentration ([Ca2+]c). A critical evaluation. J. Biol. Chem., 270, 9896-9903.
14. BRUSTOVETSKY, N. & KLINGENBERG, M. (1996). Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry, 35, 8483-8488.
15. CAIN, K., BRATTON, S.B. & COHEN, G.M. (2002). The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie, 84, 203-214.
16. CHAI, J., DU, C., WU, J.W., KYIN, S., WANG, X. & SHI, Y. (2000). Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature, 406, 855-862.
17. CHEN, L., WILLIS, S.N., WEI, A., SMITH, B.J., FLETCHER, J.I., HINDS, M.G., COLMAN, P.M., DAY, C.L., ADAMS, J.M. & HUANG, D.C. (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell, 17, 393-403.
18. CHEN, L.B. (1988). Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol., 4, 155-181.
19. CHENG, E.H., SHEIKO, T.V., FISHER, J.K., CRAIGEN, W.J. & KORSMEYER, S.J. (2003). VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science, 301, 513-517.
20. CHERNYAK, B.V. & BERNARDI, P. (1996). The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur. J. Biochem., 238, 623-630.
21. COSTANTINI, P., BELZACQ, A.S., VIEIRA, H.L., LAROCHETTE, N., DE PABLO, M.A., ZAMZAMI, N., SUSIN, S.A., BRENNER, C. & KROEMER, G. (2000a). Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene, 19, 307-314.
22. COSTANTINI, P., CHERNYAK, B.V., PETRONILLI, V. & BERNARDI, P. (1996). Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem., 271, 6746-6751.
23. COSTANTINI, P., JACOTOT, E., DECAUDIN, D. & KROEMER, G. (2000b). Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst., 92, 1042-1053.
24. CROMPTON, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem. J., 341, 233-249.
25. CROMPTON, M. (2000). Mitochondrial intermembrane junctional complexes and their role in cell death. J. Physiol., 529, 11-21.
26. CROMPTON, M., VIRJI, S. & WARD, J.M. (1998). Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem., 258, 729-735.
27. DANIEL, P.T., SCHULZE-OSTHOFF, K., BELKA, C. & GUNER, D. (2003). Guardians of cell death: the Bcl-2 family proteins. Essays Biochem., 39, 73-88.
28. DE MARCHI, U., CAMPELLO, S., SZABO, I., TOMBOLA, F., MARTINOU, J.C. & ZORATTI, M. (2004). Bax does not directly participate in the Ca(2+)-induced permeability transition of isolated mitochondria. J. Biol. Chem., 279, 37415-37422.
29. DEGLI ESPOSTI, M. & DIVE, C. (2003). Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res. Commun., 304, 455-461.
30. EKERT, P.G. & VAUX, D.L. (2005). The mitochondrial death squad: hardened killers or innocent bystanders? Curr. Opin. Cell Biol., 17, 626-630.
31. EPAND, R.F., MARTINOU, J.C., FORNALLAZ-MULHAUSER, M., HUGHES, D.W. & EPAND, R.M. (2002). The apoptotic protein tBid promotes leakage by altering membrane curvature. J. Biol. Chem., 277, 32632-32639.
32. ESKES, R., DESAGHER, S., ANTONSSON, B. & MARTINOU, J.C. (2000). Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol., 20, 929-935.
33. FAGIAN, M.M., PEREIRA-DA-SILVA, L., MARTINS, I.S. & VERCESI, A.E. (1990). Membrane protein thiol cross-linking associated with the permeabilization of the inner mitochondrial membrane by Ca2+ plus prooxidants. J. Biol. Chem., 265, 19955-19960.
34. FERNANDEZ-CHECA, J.C., GARCIA-RUIZ, C., COLELL, A., MORALES, A., MARI, M., MIRANDA, M. & ARDITE, E. (1998). Oxidative stress: role of mitochondria and protection by glutathione. Biofactors, 8, 7-11.
35. FRUMAN, D.A., KLEE, C.B., BIERER, B.E. & BURAKOFF, S.J. (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. U.S.A., 89, 3686-3690.
36. GADELHA, F.R., THOMSON, L., FAGIAN, M.M., COSTA, A.D., RADI, R. & VERCESI, A.E. (1997). Ca2+-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch. Biochem. Biophys., 345, 243-250.
37. GAO, W., PU, Y., LUO, K.Q. & CHANG, D.C. (2001). Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J. Cell Sci., 114, 2855-2862.
38. GORDON, D.M., DANCIS, A. & PAIN, D. (2000). Mechanisms of mitochondrial protein import. Essays Biochem., 36, 61-73.
39. GOTTLIEB, R.A. (2000). Mitochondria: execution central. FEBS Lett., 482, 6-12.
40. GREEN, D.R. & KROEMER, G. (2004). The pathophysiology of mitochondrial cell death. Science, 305, 626-629.
41. GREEN, D.R. & REED, J.C. (1998). Mitochondria and apoptosis. Science, 281, 1309-1312.
42. GRIFFITH, O.W. & MEISTER, A. (1985). Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. U.S.A., 82, 4668-4672.
43. GUO, B., ZHAI, D., CABEZAS, E., WELSH, K., NOURAINI, S., SATTERTHWAIT, A.C. & REED, J.C. (2003). Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature, 423, 456-461.
44. HALESTRAP, A.P., CLARKE, S.J. & JAVADOV, S.A. (2004). Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc. Res., 61, 372-385.
45. HALESTRAP, A.P., MCSTAY, G.P. & CLARKE, S.J. (2002). The permeability transition pore complex: another view. Biochimie, 84, 153-166.
46. HAWORTH, R.A. & HUNTER, D.R. (1979). The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch. Biochem. Biophys., 195, 460-467.
47. HIRSCH, T., DECAUDIN, D., SUSIN, S.A., MARCHETTI, P., LAROCHETTE, N., RESCHE-RIGON, M. & KROEMER, G. (1998). PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res., 241, 426-434.
48. HOCKENBERY, D.M., OLTVAI, Z.N., YIN, X.M., MILLIMAN, C.L. & KORSMEYER, S.J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
49. IRVINE, R.A., ADACHI, N., SHIBATA, D.K., CASSELL, G.D., YU, K., KARANJAWALA, Z.E., HSIEH, C.L. & LIEBER, M.R. (2005). Generation and characterization of endonuclease G null mice. Mol. Cell. Biol., 25, 294-302.
50. ITO, T., DENG, X., CARR, B. & MAY, W.S. (1997). Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem., 272, 11671-11673.
51. JACOTOT, E., RAVAGNAN, L., LOEFFLER, M., FERRI, K.F., VIEIRA, H.L., ZAMZAMI, N., COSTANTINI, P, DRUILLENNEC, S., HOEBEKE, J., BRIAND, J.P., IRINOPOULOU, T., DAUGAS, E., SUSIN, S.A., COINTE, D., XIE, Z.H., REED, J.C., ROQUES, B.P. & KROEMER, G. (2000). The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med., 191, 33-46.
52. JIN, S., KALKUM, M., OVERHOLTZER, M., STOFFEL, A., CHAIT, B.T. & LEVINE, A.J. (2003). CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev., 17, 359-367.
53. JONES, J.M., DATTA, P., SRINIVASULA, S.M., JI, W., GUPTA, S., ZHANG, Z., DAVIES, E., HAJNOCZKY, G., SAUNDERS, T.L., VAN KEUREN, M.L., FERNANDES-ALNEMRI, T., MEISLER, M.H. & ALNEMRI, E.S. (2003). Loss of OMI mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature, 425, 721-727.
54. KAGAWA, S., PEARSON, S.A., JI, L., XU, K., MCDONNELL, T.J., SWISHER, S.G., ROTH, J.A. & FANG, B. (2000). A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Therapy, 7, 75-79.
55. KIM, J.S., HE, L., QIAN, T. & LEMASTERS, J.J. (2003). Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr. Mol. Med., 3, 527-535.
56. KORSMEYER, S.J., WEI, M.C., SAITO, M., WEILER, S., OH, K.J. & SCHLESINGER, P.H. (2000). Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ., 7, 1166-1173.
57. KOWALTOWSKI, A.J., CASTILHO, R.F. & VERCESI, A.E. (2001). Mitochondrial permeability transition and oxidative stress. FEBS Lett., 495, 12-15.
58. KROEMER, G. (2002). Introduction: mitochondrial control of apoptosis. Biochimie, 84, 103-104.
59. KUWANA, T. & NEWMEYER, D.D. (2003). Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol., 15, 691-699.
60. LAROCHETTE, N., DECAUDIN, D., JACOTOT, E., BRENNER, C., MARZO, I., SUSIN, S.A., ZAMZAMI, N., XIE, Z., REED, J. & KROEMER, G. (1999). Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res., 249, 413-421
61. LAWRENCE, J.W., CLAIRE, D.C., WEISSIG, V. & ROWE, T.C. (1996). Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol. Pharmacol., 50, 1178-1188.
62. LEMASTERS, J.J., NIEMINEN, A.L., QIAN, T., TROST, L.C., ELMORE, S.P., NISHIMURA, Y., CROWE, R.A., CASCIO, W.E., BRADHAM, C.A., BRENNER, D.A. & HERMAN, B. (1998). The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta, 1366, 177-196.
63. LI, L., THOMAS, R.M., SUZUKI, H., DE BRABANDER, J.K., WANG, X. & HARRAN, P.G. (2004). A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science, 305, 1471-1474.
64. LI, X., MARANI, M., YU, J., NAN, B., ROTH, J.A., KAGAWA, S., FANG, B., DENNER, L. & MARCELLI, M. (2001). Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res., 61, 186-191.
65. MARCHETTI, P., CASTEDO, M., SUSIN, S.A., ZAMZAMI, N., HIRSCH, T., MACHO, A., HAEFFNER, A., HIRSCH, F., GEUSKENS, M. & KROEMER, G. (1996). Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med., 184, 1155-1160.
66. MARCHETTI, P., ZAMZAMI, N., JOSEPH, B., SCHRAEN-MASCHKE, S., MEREAU-RICHARD, C., COSTANTINI, P., METIVIER, D., SUSIN, S.A., KROEMER, G. & FORMSTECHER, P. (1999). The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]- 2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res., 54, 6257-6266.
67. MARCUCCI, G., STOCK, W., DAI, G., KLISOVIC, R.B., LIU, S., KLISOVIC, M.I., BLUM, W., KEFAUVER, C., SHER, D.A., GREEN, M., MORAN, M., MAHARRY, K., NOVICK, S., BLOOMFIELD, C.D., ZWIEBEL, J.A., LARSON, R.A., GREVER, M.R., CHAN, K.K. & BYRD, J.C. (2005). Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. J. Clin. Oncol., 23, 3404-3411.
68. MARTENSSON, J., LAI, J.C. & MEISTER, A. (1990). High-affinity transport of glutathione is part of a multicomponent system essential for mitochondrial function. Proc. Natl. Acad. Sci. U.S.A., 87, 7185-7189.
69. MARTINOU, I., DESAGHER, S., ESKES, R., ANTONSSON, B., ANDRE, E., FAKAN, S. & MARTINOU, J.C. (1999). The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell Biol., 144, 883-889.
70. MARTINS, L.M., MORRISON, A., KLUPSCH, K., FEDELE, V., MOISOI, N., TEISMANN, P., ABUIN, A., GRAU, E., GEPPERT, M., LIVI, G.P., CREASY, C.L., MARTIN, A., HARGREAVES, I., HEALES, S.J., OKADA, H., BRANDNER, S., SCHULZ, J.B., MAK, T. & DOWNWARD, J. (2004). Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol., 24, 9848-9862.
71. MARZO, I., BRENNER, C., ZAMZAMI, N., JURGENSMEIER, J.M., SUSIN, S.A., VIEIRA, H.L., PREVOST, M.C., XIE, Z., MATSUYAMA, S., REED, J.C. & KROEMER, G. (1998). Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science, 281, 2027-2031.
72. MATE, M.J., ORTIZ-LOMBARDIA, M., BOITEL, B., HAOUZ, A., TELLO, D., SUSIN, S.A., PENNINGER, J., KROEMER, G. & ALZARI, P.M. (2002). The crystal structure of the mouse apoptosis-inducing factor AIF. Nat. Struct. Biol., 9, 442-446.
73. MCENERY, M.W., SNOWMAN, A.M., TRIFILETTI, R.R. & SNYDER, S.H. (1992). Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U.S.A., 89, 3170-3174.
74. MIRAMAR, M.D., COSTANTINI, P., RAVAGNAN, L., SARAIVA, L.M., HAOUZI, D., BROTHERS, G., PENNINGER, J.M., PELEATO, M.L., KROEMER, G. & SUSIN, S.A. (2001). NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem., 276, 16391-16398.
75. MIYASHITA, T. & REED, J.C. (1992). Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52, 5407-5411.
76. MODICA-NAPOLITANO, J.S., KOYA, K., WEISBERG, E., BRUNELLI, B.T., LI, Y. & CHEN, L.B. (1996). Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res., 56, 544-550.
77. MURPHY, M.P. (1997). Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol., 15, 326-330.
78. NAKAGAWA, T., SHIMIZU, S., WATANABE, T., YAMAGUCHI, O., OTSU, K., YAMAGATA, H., INOHARA, H., KUBO, T. & TSUJIMOTO, Y. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 434, 652-658.
79. NECHUSHTAN, A., SMITH, C.L., HSU, Y.T. & YOULE, R.J. (1999). Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J., 18, 2330-2341.
80. NOMURA, M., SHIMIZU, S., SUGIYAMA, T., NARITA, M., ITO, T., MATSUDA, H. & TSUJIMOTO, Y. (2003). 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J. Biol. Chem., 278, 2058-2065.
81. OKAMAOTO, M., OHSATO, T., NAKADA, K., ISOBE, K., SPELBRINK, J.N., HAYASHI, J., HAMASAKI, N. & KANG, D. (2003). Ditercalinium chloride, a pro-anticancer drug, intimately associates with mammalian mitochondrial DNA and inhibits its replication. Curr. Genet., 43, 364-370.
82. PETRONILLI, V., COSTANTINI, P., SCORRANO, L., COLONNA, R., PASSAMONTI, S. & BERNARDI, P. (1994). The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem., 269, 16638-16642.
83. PETROSILLO, G., RUGGIERO, F.M. & PARADIES, G. (2003). Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J., 17, 2202-2208.
84. PFEIFFER, D.R., GUDZ, T.I., NOVGORODOV, S.A. & ERDAHL, W.L. (1995). The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition. J. Biol. Chem., 270, 4923-4932.
85. RAVAGNAN, L., MARZO, I., COSTANTINI, P., SUSIN, S.A., ZAMZAMI, N., PETIT, P.X., HIRSCH, F., GOULBERN, M., POUPON, M.F., MICCOLI, L., XIE, Z., REED, J.C. & KROEMER, G. (1999). Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene, 18, 2537-2546.
86. SAWADA, M., SUN, W., HAYES, P., LESKOV, K., BOOTHMAN, D.A. & MATSUYAMA, S. (2003). Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell Biol., 5, 320-329.
87. SCHEFFLER, I.E. (2001). Mitochondria make a come back. Adv. Drug Deliv. Rev., 49, 3-26.
88. SCHINDER, A.F., OLSON, E.C., SPITZER, N.C. & MONTAL, M. (1996). Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci., 16, 6125-6133.
89. SCHINZEL, A., KAUFMANN, T., SCHULER, M., MARTINALBO, J., GRUBB, D. & BORNER, C. (2004). Conformational control of Bax localization and apoptotic activity by Pro168. J. Cell Biol., 164, 1021-1032. [Epub 2004 Mar 22].
90. SCHULER, W., WECKER, K., DE ROCQUIGNY, H., BAUDAT, Y., SIRE, J. & ROQUES, B.P. (1999). NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J. Mol. Biol., 285, 2105-2117.
91. SCHULTZ, D.R. & HARRINGTON JR, W.J. (2003). Apoptosis: programmed cell death at a molecular level. Semin. Arthritis Rheum., 32, 345-369.
92. SEDLAK, T.W., OLTVAI, Z.N., YANG, E., WANG, K., BOISE, L.H., THOMPSON, C.B. & KORSMEYER, S.J. (1995). Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. U.S.A., 92, 7834-7838.
93. SHI, Y. (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell, 9, 459-470.
94. SMAILI, S.S., HSU, Y.T., YOULE, R.J. & RUSSELL, J.T. (2000). Mitochondria in Ca2+ signaling and apoptosis. J. Bioenerg. Biomembr., 32, 35-46.
95. STEINMAN, H.M. (1995). The Bcl-2 oncoprotein functions as a pro-oxidant. J. Biol. Chem., 270, 3487-3490.
96. STRYKER, J.A. & GERWECK, L.E. (1988). Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization. Radiat. Res., 113, 356-361.
97. SUSIN, S.A., LORENZO, H.K., ZAMZAMI, N., MARZO, I., SNOW, B.E., BROTHERS, G.M., MANGION, J., JACOTOT, E., COSTANTINI, P., LOEFFLER, M., LAROCHETTE, N., GOODLETT, D.R., AEBERSOLD, R., SIDEROVSKI, D.P., PENNINGER, J.M. & KROEMER, G. (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446.
98. SUSIN, S.A., ZAMZAMI, N., CASTEDO, M., HIRSCH, T., MARCHETTI, P., MACHO, A., DAUGAS, E., GEUSKENS, M. & KROEMER, G. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184, 1331-1341.
99. SUZUKI, Y., IMAI, Y., NAKAYAMA, H., TAKAHASHI, K., TAKIO, K. & TAKAHASHI, R. (2001). A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell, 8, 613-621.
100. VAHSEN, N., CANDE, C., BRIERE, J.J., BENIT, P., JOZA, N., LAROCHETTE, N., MASTROBERARDINO, P.G., PEQUIGNOT, M.O., CASARES, N., LAZAR, V., FERAUD, O., DEBILI, N., WISSING, S., ENGELHARDT, S., MADEO, F., PIACENTINI, M., PENNINGER, J.M., SCHAGGER, H., RUSTIN, P. & KROEMER, G. (2004). AIF deficiency compromises oxidative phosphorylation. EMBO J., 23, 4679-4689.
101. VAN LOO, G., SAELENS, X., VAN GURP, M., MACFARLANE, M., MARTIN, S.J. & VANDENABEELE, P. (2002). The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ., 9, 1031-1042.
102. VANDER HEIDEN, M.G., CHANDEL, N.S., WILLIAMSON, E.K., SCHUMACKER, P.T. & THOMPSON, C.B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91, 627-637.
103. VON AHSEN, O., RENKEN, C., PERKINS, G., KLUCK, R.M., BOSSY-WETZEL, E. & NEWMEYER, D.D. (2000). Preservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. J. Cell Biol., 150, 1027-1036.
104. WAJANT, H. (2002). The Fas signaling pathway: more than a paradigm. Science, 296, 1635-1636.
105. WALDMEIER, P.C., ZIMMERMANN, K., QIAN, T., TINTELNOT-BLOMLEY, M. & LEMASTERS, J.J. (2003). Cyclophilin D as a drug target. Curr. Med. Chem., 10, 1485-1506.
106. WALENSKY, L.D., KUNG, A.L., ESCHER, I., MALIA, T.J., BARBUTO, S., WRIGHT, R.D., WAGNER, G., VERDINE, G.L. & KORSMEYER, S.J. (2004). Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science, 305, 1466-1470.
107. WARING, P. & BEAVER, J. (1996). Cyclosporin A rescues thymocytes from apoptosis induced by very low concentrations of thapsigargin: effects on mitochondrial function. Exp. Cell Res., 227, 264-276.
108. WIDLAK, P. & GARRARD, W.T. (2005). Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J. Cell Biochem., 94, 1078-1087.
109. WOODFIELD, K., RUCK, A., BRDICZKA, D. & HALESTRAP, A.P. (1998). Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J., 336, 287-290.
110. WU, G., CHAI, J., SUBER, T.L., WU, J.W., DU, C., WANG, X. & SHI, Y. (2000). Structural basis of IAP recognition by Smac/DIABLO. Nature, 408, 1008-1012.
111. XIANG, J., GOMEZ-NAVARRO, J., ARAFAT, W., LIU, B., BARKER, S.D., ALVAREZ, R.D., SIEGAL, G.P. & CURIEL, D.T. (2000). Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer. J. Gene Med., 2, 97-106.
112. YIN, X.M., OLTVAI, Z.N. & KORSMEYER, S.J. (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 369, 321-323.
113. ZAMZAMI, N., MARZO, I., SUSIN, S.A., BRENNER, C., LAROCHETTE, N., MARCHETTI, P., REED, J., KOFLER, R. & KROEMER, G. (1998). The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene, 16, 1055-1063.
114. ZHU, X.H., SHEN, Y.L., JING, Y.K., CAI, X., JIA, P.M., HUANG, Y., TANG, W., SHI, G.Y., SUN, Y.P., DAI, J., WANG, Z.Y., CHEN, S.J., ZHANG, T.D., WAXMAN, S., CHEN, Z. & CHEN, G.Q. (1999). Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst., 91, 772-778.
115. ZORATTI, M. & SZABO, I. (1995). The mitochondrial permeability transition. Biochim. Biophys. Acta, 124, 139-176.